Clinical Trial Update: [68Ga]Ga-FAPI-46 in Staging of Head and Neck Carcinomas [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating the imaging agent [68Ga]Ga-FAPI-46 for staging head and neck squamous cell carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• [68Ga]Ga-FAPI-46

Snippet

Sponsor: John O. Prior | Conditions: Head and Neck Squamous Cell Carcinoma HNSCC | Phase 2 | Status: RECRUITING